|
MAPK6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.147590E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.186200E-01 |
| Normal-vs-Stage2 |
1.168180E-01 |
| Normal-vs-Stage3 |
3.324500E-02 |
| Normal-vs-Stage4 |
1.011050E-01 |
| Stage1-vs-Stage2 |
4.939800E-01 |
| Stage1-vs-Stage3 |
5.642200E-02 |
| Stage1-vs-Stage4 |
4.348600E-01 |
| Stage2-vs-Stage3 |
5.366400E-01 |
| Stage2-vs-Stage4 |
9.428400E-01 |
| Stage3-vs-Stage4 |
5.842400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.347190E-01 |
| Normal-vs-AfricanAmerican |
9.204000E-01 |
| Normal-vs-Asian |
1.557020E-01 |
| Caucasian-vs-AfricanAmerican |
1.827200E-01 |
| Caucasian-vs-Asian |
7.009800E-01 |
| AfricanAmerican-vs-Asian |
2.101400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.839900E-02 |
| Normal-vs-Female |
1.497820E-01 |
| Male-vs-Female |
3.335000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.600400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.502000E-02 |
| Normal-vs-Age(61-80Yrs) |
2.665800E-02 |
| Normal-vs-Age(81-100Yrs) |
7.100200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.056500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.563200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.430000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.495400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.098000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.166800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.392270E-02 |
| Classical-VS-Follicular |
4.859700E-02 |
| Classical-VS-Other |
1.445030E-01 |
| Classical-VS-Normal |
3.257000E-01 |
| Tall-VS-Follicular |
5.307600E-01 |
| Tall-VS-Other |
4.711200E-01 |
| Tall-VS-Normal |
2.237800E-02 |
| Follicular-VS-Other |
3.896800E-01 |
| Follicular-VS-Normal |
5.021800E-02 |
| Other-VS-Normal |
1.642180E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.318100E-02 |
| Normal-vs-N1 |
1.214170E-01 |
| N0-vs-N1 |
3.937200E-01 |
|
|
